Skip to content

Clinical trials

Completed Purpura, Thrombocytopenic, Idiopathic trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Status: Completed Country / region: Spain Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20081
20092
20101
20121
20143
20151
20161
20171
20182
20192
20204
20211
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen4
argenx4
GlaxoSmithKline3
Novartis Pharmaceuticals2
Rigel Pharmaceuticals2
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Biotest1
Bioverativ, a Sanofi company1
European Research Consortium on ITP1
Fundacion CRIS de Investigación para Vencer el Cáncer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic26
Thrombocytopenia5
Purpura3
Anemia, Hemolytic1
Anemia, Hemolytic, Autoimmune1
Blood Platelet Disorders1
Hemorrhage1
Myelodysplastic Syndromes1
Recurrence1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.